Diabetes
Diabetes has been diagnosed in about 11 million people in the United States. People with diabetes do not properly produce insulin, which is necessary to regulate sugars and starches. While pancreas and islet transplants end reliance on insulin injections for some, there is a shortage of donors. In the United States, there are more than 30,000 new cases of type 1 diabetes each year but only 3,000 potential donors whose pancreases are suitable. Currently, there is no cure for diabetes.
Stem cells offer promise to those with diabetes. If stem cells could be cultivated to become cells that produce insulin, they could solve the problem of donor shortage. If a stem-cell therapy could be developed, it would also help relieve diabetes-related diseases of the kidneys, eyes, nerves, and veins.
To treat diabetes, stem cells need to be cultivated into insulin-producing cells. Once that has been accomplished, researchers expect to transplant stem cells that have been cultivated into insulin-producing cells into diabetic patients. Currently, those who receive transplants must take drugs that suppress the immune system. If a persons own stem cells could be cultivated and used for transplant, those drugs would not be needed. Ultimately, researchers hope to cure diabetes.
Cardiovascular diseases affect nearly 62 million people and is the number-one cause of death in the United States.
Stem cells offer hope to those with heart disease because they might be able to replace damaged cardiac muscle or stimulate the growth of new heart-muscle cells from existing progenitor cells. Because natural regeneration of heart muscle is very inefficient, those who now suffer from a heart attack, from congenital heart disease, or from congestive heart failure have few treatment options. And while heart transplants potentially could help more patients, the supply of organs is limited.
Clinical trials using a patients own stem cells, derived from bone marrow, have already been carried out in United States and Europe, but few grafted cells survive and the benefits are very modest. Current work by stem cell researchers at the University of Minnesota focuses on identifying cardiac progenitor cells and devising new methods to create cardiac progenitor cells from embryonic stem cells or induced pluripotent stem cells.
Liver diseases such as cirrhosis and hepatitis affect 25 million people in the United States and represent the seventh most common cause of death in the United States. Liver transplantation can help some but there is an extreme shortage of transplantable organs. Although more than 18,000 people currently await liver transplantation in the United States, only 5,000 organs will be transplanted in the next year.
Stem cells offer promise both to people born with liver problems and to those who develop liver disease later in life. Those born with liver disease caused by a genetic error potentially could be treated by a relatively small amount of liver cells. These cells could relieve the symptoms of liver disease or the genetic error could potentially be corrected by gene therapy.
In cases of acute liver failure in adults, stem cell therapies might be used to support the liver for a period of time. If the therapy works, patients livers would gain time to recover. There are indications that some forms of viral hepatitis might be treated with stems cells as well.
Researchers at the U are exploring using stem cells in a liver-support device, repairing genes with liver stem cells, and infusing stem cells into liver portal veins. A team focusing on liver disease has made progress in the areas of liver support and gene repair. Some disease treatments may be limited to support but other diseases might be cured with stem cells. Applicable treatments are still five or more years in the future; at this time, there are no plans for human clinical trials.
Theres a mistake in some of these genes. And if we could rewrite that code, Alzheimers, Parkinsons, liver conditionsit would work for all of them. Jakub Tolar, MD, PhD
University of Minnesota researchers are focusing on finding novel treatments for Parkinsons disease using stem cells. Parkinsons disease, which affects a million people in the United States, often begins as a tremor in the hands or feet. Patients later develop trouble with walking and other daily activities as control over the body erodes. While some patients manage their symptoms, there is no cure for Parkinsons disease.
Stem cells offer hope to those with Parkinsons disease, which is caused by the loss of nerve cells in the brain. These nerve cells produce a neurotransmitter called dopamine. If stem cells can be cultivated to become these dopamine-producing nerve cells, researchers believe that they could replace the lost cells.
Other disorders of the brain or nervous system that might be treated with stem cells include stroke, ALS (Lou Gehrigs disease), multiple sclerosis, Huntingtons disease, Alzheimers disease, and spinal cord injuries.
The treatment method being explored is transplanting appropriate cells into the target sites of the brain that need dopamine. Because Parkinsons disease is caused by the failure of one type of cell to do its jobthe dopamine-producing cells in the thalamusParkinsons is believed to be one of the most likely beneficiaries of stem cell research.
Treatments for humans are still years away. At this time, it is hard to pinpoint when human clinical trials might begin, as complex research often encounters unexpected hurdles. With current progress in stem cell research, however, researchers believe they may one day cure Parkinsons disease.
The rest is here:
The Promise of Stem Cells | Stem Cell Institute ...
- Stem cell treatment after spinal cord injury: The next steps - Mayo Clinic - December 18th, 2022
- A CRISPR Alternative for Correcting Mutations That Sensitize Cells to DNA Damage - The Scientist - October 13th, 2022
- The Switch to Regenerative Medicine - Dermatology Times - October 13th, 2022
- A history of blood cancer treatment - - pharmaphorum - September 16th, 2022
- What Are Zombie Cells? Here's How They Impact Aging - Prevention Magazine - September 8th, 2022
- ThreeSixty Journalism: Be The Match works to build equity in access to bone marrow and cord blood transplants - St. Paul Pioneer Press - September 8th, 2022
- Zhang and colleagues win an $11.2 million NIH program project grant (PPG) - News - University of Alabama at Birmingham - August 22nd, 2022
- Kyle Vining: Appointment to Faculty of Penn Dental Medicine and Penn School of Engineering and Applied Science - University of Pennsylvania - August 22nd, 2022
- Gamida Cell Announces Dosing of First Patient in Company-Sponsored Phase 1/2 Study of NK Cell Therapy Candidate GDA-201 - Business Wire - August 14th, 2022
- Engineers develop new tool that will allow for more personalized cell therapies - UMN News - July 27th, 2022
- University of Minnesota scientist responds to fraud allegations in Alzheimer's research - Star Tribune - July 27th, 2022
- Accelerating Transformational Research into Cell Transplantation for Patients with Type 1 Diabetes - UCSF - July 27th, 2022
- TC BioPharm Announces Formation of Scientific Advisory Board with Renowned Cell Therapy Experts - GuruFocus.com - July 11th, 2022
- Witt Wolfpack: Family works out fundraising and awareness after La Jollan's ALS diagnosis - La Jolla Light - July 11th, 2022
- Pluripotent stem cellderived NK cells with high-affinity noncleavable ... - July 3rd, 2022
- Life-saving lecture: Auburn student uses lessons from class to help discover father's brain tumor - Office of Communications and Marketing - June 22nd, 2022
- Bluebird's future in balance as FDA weighs gene therapy approvals - BioPharma Dive - June 13th, 2022
- Be the Match is looking for more ethnically diverse donors to help patients with blood cancers and diseases - KARE11.com - June 4th, 2022
- Minnesota woman reunites with teenager she saved through Be The Match transplant - KSTP - April 19th, 2022
- Induced Pluripotent Stem Cells and Their Potential for ... - November 22nd, 2021
- Cells or drugs? The race to regenerate the heart - Scientific American - November 8th, 2021
- Four-year-old with rare disease finally gets historic gene therapy treatment - KARE11.com - October 5th, 2021
- Caribou Biosciences Appoints Biotechnology Industry Veteran Ran Zheng to its Board of Directors - Stockhouse - October 5th, 2021
- EDITORIAL: The need is vast. Consider becoming an organ donor. - Yahoo News - August 18th, 2021
- Our View: The need is vast. Consider becoming an organ donor. - PostBulletin.com - August 18th, 2021
- Negrin Shines Light on the Orca-T Story in GVHD - OncLive - December 11th, 2020
- COVID-19 and the trials of treatment | News, Sports, Jobs - Escanaba Daily Press - October 16th, 2020
- NMDP/Be The Match partners with M Health Fairview and Duke University cryopreservation labs to launch Be The Match BioBank - Watauga Democrat - October 7th, 2020
- Berks County's first STEM-themed attraction opens, delights visitors young and old - Reading Eagle - October 7th, 2020
- Coronavirus Thursday update: UMN announces new stem cell ... - August 16th, 2020
- University of Minnesota launches stem cell trial against ... - August 16th, 2020
- University of Minnesota launches stem cell trial against severe COVID-19 - Minneapolis Star Tribune - August 16th, 2020
- Biotechnology Could Change the Cattle Industry. Will It Succeed? - Singularity Hub - August 16th, 2020
- Fate Therapeutics Announces First Patient Treated in First-in-human Clinical Trial of FT596 and Provides Corporate Update - Yahoo Finance - April 4th, 2020
- A word for those risking their lives amid the coronavirus crisis: Thanks - TwinCities.com-Pioneer Press - April 4th, 2020
- Coronavirus is similar to SARS and causes infection through a heart regulating enzyme: Study - International Business Times, Singapore Edition - February 4th, 2020
- Why Sangamo Therapeutics Stock Sank Today - The Motley Fool - December 13th, 2019
- Hoeven's bill supports alternative therapy for veterans with PTSD, traumatic brain injury - Ripon Advance - October 1st, 2019
- Stem-cell treatment gives two brothers a future ... - March 3rd, 2019
- 2018 Regenerative Medicine Minnesota Research Awards - August 17th, 2018
- FDA cracks down on stem cell clinics - CNN - August 29th, 2017
- Mayo Clinic, University of Minnesota develop 'robocop' stem cells to fight cancer - Minneapolis Star Tribune - August 24th, 2017
- Cowboy Up Ride Against Cancer - Wahpeton Daily News - August 24th, 2017
- Cargill invests in 'clean meat' start-up - KARE - August 24th, 2017
- Stem-cell clinics are using a federal website as a marketing tool for unproven treatments, U of M bioethicist says - MinnPost - July 30th, 2017
- More than 60 US clinics have sold unproven stem cell therapies for heart failure - New York Post - July 30th, 2017
- Stemonix, a stem cell research firm, wins Minnesota Cup ... - November 27th, 2016
- Minnesotas Funding of Stem Cell Research Echoes Trend ... - October 29th, 2016
- Stem cell research Experts@Minnesota - October 18th, 2016
- Stem Cell FAQs - Minnesota Regenerative Medicine - October 7th, 2016
- Minnesota invests in regenerative medicine - Health Talk - October 7th, 2016
- Minnesota to resume umbilical cord blood donations ... - September 20th, 2016
- STEM Programs - Minnesota Zoo - September 5th, 2016
- Stem Cell Treatment - Minnesota Regenerative Medicine - August 18th, 2016
- Home - Minnesota Regenerative Medicine - August 18th, 2016
- Multipotent vs. pluripotent stem cells - Pathology Student - October 19th, 2015
- 2. Bone Marrow (Hematopoietic) Stem Cells [Stem Cell ... - October 19th, 2015
- Minnesota Man With ALS Hopes Stem Cells Save His Life ... - July 2nd, 2015
- Graduate Programs - MED - Stem Cell Institute, University ... - April 26th, 2015
- Atsushi Asakura, Ph.D. - MED - Stem Cell Institute ... - March 18th, 2015
- Bioelectricity Plays Key Role in Brain Development & Repair - March 13th, 2015
- Jakub Tolar, M.D., Ph.D. - MED - Stem Cell Institute ... - February 24th, 2015
- Stem Cell Web Focus - Nature Publishing Group : science ... - February 3rd, 2015
- Family: Experimental stem-cell treatment does wonders for Gordie Howe - December 20th, 2014
- Childrens hospital gets $25M - December 16th, 2014
- Stem Cell Malaysia Blog - December 12th, 2014
- Reduction of germ cells yields more zebrafish males - December 4th, 2014
- Cardio3 BioSciences Announces the Nomination of Three Co-Principal Investigators for Its CHART-2 Phase III Clinical ... - November 28th, 2014
- Mayo Clinic Researchers Identify First Steps in Formation of Pancreatic Cancer - November 10th, 2014
- Anti-Cancer Drug Effective Against Common Stem Cell Transplant Complication - October 24th, 2014
- $25M gift prompts University pediatric hospital name change - October 16th, 2014
- Becoming a blood stem cell or bone marrow donor ... - October 3rd, 2014
- New heart built with stem cells - YouTube - September 27th, 2014
- Cancer Survivor Saved by Measles Virus Raises Funds for Expanded Trial - September 12th, 2014
- Researchers find animal model for understudied type of muscular dystrophy - August 30th, 2014
- Minnesota Stem Cell Therapy | Stem Cell Treatments - August 29th, 2014
- Stem Cell FAQs - MED - Stem Cell Institute, University of ... - August 22nd, 2014
- Home - MED - Stem Cell Institute, University of Minnesota - August 22nd, 2014
- Stem cells | Health Sciences - University of Minnesota - August 22nd, 2014